|
|
 |
|
 |
|
|



|
| September 9, 8:45-10:30 |
Pegasus1
|
|
| |
|
Moderator
|
 |
Co-Moderator
|
| 1. |
Education and Safety of Cardiac Anesthesia
(World Prospective of Risk Reduction) |
J. Takeda
|
|
P. Duke
|
|
 |
1) |
New Developments in Risk Reduction and Outcome Improvement
| a. |
Cardiac Anesthesia Safety and Education - North
America
|
 |
D.
Reich |
| b. |
Education and Safety of Cardiac Anesthesia New
Development in Risk Reduction and Outcome Improvement
|
 |
U.
Prakanrattana |
| c. |
The Anesthesiologist Role in Risk Reduction and
Outcome Improvement in Cardiac Surgery |
|
B.
Drenger |
|
|
2) |
Computer-assisted Cardiovascular Anesthesia
| a. |
Navigation System for Anesthetist
|
 |
N.
Okude |
| b. |
From Siumulator to Navigator: Anesthetic Practice
|
 |
R. Ochiai |
|
|
|
|
|
|
|
| September 9, 9:00-10:30 |
Orion
|
|
|
|
Moderator |
|
Co-Moderator |
| 2. |
Thoracic Anesthesia |
P. Slinger |
|
S. Morita |
|
 |
1) |
Anesthetic Considerations in One-Lung Ventilation and
Techniques for Lung Isolation |
 |
P. Slinger |
|
2) |
Perioperative Management of the Lung Transplant Recipient |
|
M. Dickstein |
|
3) |
Perioperative Management of Esophageal Resection |
|
H.
Naitou |
|
|
|
|
|
|
|
|
| September 9, 11:00-12:00 |
Pegasus1
|
|
|
|
Moderator |
|
Co-Moderator |
| 3. |
Scientific Approaches for Cardiovascular System |
B. Riedel |
|
K. Sumikawa |
|
 |
1) |
Development of Regenerated Cardiomyocytes from Bone
Marrow Mesenchymal Stem Cells for Cardiovascular Tissue
Engineering |
 |
K. Fukuda |
|
2) |
A New Paradigm in cAMP Signal |
|
Y. Ishikawa |
|
|
|
|
|
|
|
|
| September 9, 11:00-12:00 |
Orion
|
|
|
|
Moderator |
|
|
| 4. |
Literature Review Japanese |
S. Fukuda |
|
|
|
|
|
|
|
|
|
| September 9, 13:45-15:15 |
Apollon
|
|
|
|
Moderator |
|
Co-Moderator |
| 5. |
Coagulation |
L. Shore
-Lesserson |
|
K. Morita |
|
 |
1) |
Coagulation Changes during Cardiopulmonary Bypass |
 |
M. Ereth |
|
2) |
Platelet Monitoring in the Perioperative Period |
|
K. Tanaka |
|
3) |
Does the Use of Antifibrinolytics Reduce Bleeding during
and after Cardiac Surgery? |
|
L. Shore-Lesserson |
|
|
|
|
|
|
|
|
| September 9, 13:45-15:15 |
Orion
|
|
|
|
Moderator |
|
Co-Moderator |
| 6. |
Cardiopulmonary Bypass |
J. Murkin |
|
H. Kato |
|
 |
1) |
Embolic Events during Heart Surgery: Detection and Prevention |
 |
J. Murkin |
|
2) |
Dialysis and Hemofiltration in Cardiac Surgery |
|
Y. Miyamoto |
|
3) |
The Role of Recombinant Factor Vlla in Cardiac Surgery |
|
D. Mazer |
|
|
|
|
|
|
|
|
| September 9, 15:45-16:45 |
Apollon
|
|
|
|
Moderator |
|
Co-Moderator |
| 7. |
Management of the Patient with Heart Disease |
L. Ti |
|
R. Chuma |
|
 |
1) |
Preoperative Assessment of the Patient with Cardiac
Disease |
 |
D. Mangano |
|
2) |
New Management Options in Valvular Heart Disease |
|
S. Konstadt |
|
|
|
|
|
|
|
|
| September 10, 9:00-10:30 |
Pegasus1
|
|
|
|
Moderator |
|
Co-Moderator |
| 8. |
Off-pump Coronary Artery Bypass |
M. Howie |
|
H. Furuya |
|
 |
1) |
OPCAB Is it Better? |
 |
N. Schwann |
|
2) |
Reduction of Ischemia during OPCAB |
|
Y. L.
Kwak |
|
3) |
The Future of Coronary Bypass Surgery |
|
J. Kobayashi |
|
|
|
|
|
|
|
|
| September 10, 9:00-10:30 |
Orion
|
|
|
|
Moderator |
|
Co-Moderator |
| 9. |
Postoperative Management in Cardiac Patients |
J. Ramsay |
|
S. Hoka |
|
 |
1) |
Postoperative Atrial Fibrillation |
 |
J. Ramsay |
|
2) |
Postoperative Respiratory Management |
|
R. Sladen |
|
3) |
Postoperative Pain Management following Cardiac Surgery |
|
M. Chaney |
|
|
|
|
|
|
|
|
| September 10, 11:00-12:00 |
Pegasus1
|
|
|
|
Moderator |
|
Co-Moderator |
| 10. |
Management for Aortic Stenosis |
G. Roach |
|
R. Yozu |
|
 |
1) |
Preoperative and Intraoperative Evaluation of the Aortic
Valve |
 |
C. Troianos |
|
2) |
Surgical Options for Aortic Valve Procedure |
|
H. Kurosawa |
|
|
|
|
|
|
|
|
| September 10, 11:00-12:00 |
Orion
|
|
|
|
Moderator |
|
Co-Moderator |
| 11. |
Literature Review International Pharmacology |
K. Cvachovec |
|
E. Inada |
|
 |
1) |
Anticoagulation, Coagulation, and Haemostatics: Any
New Drugs? |
 |
G. Gravlee |
|
2) |
Treatment Innovations for Adult Cardiovascular Disease:
2003-2004 |
|
D. Cook |
|
3) |
Perioperative Stroke and Cognitive Dysfunction? Any
Role for Pharmacotherapy? |
|
Mora Mangano |
|
|
|
|
|
|
|
|
| September 10, 13:30-15:00 |
Pegasus1
|
|
|
|
Moderator |
|
Co-Moderator |
| 12. |
Imflammatory Response in Cardiac Surgery |
J. Levy |
|
M. Kuro |
|
 |
1) |
Mechanism of the Inflammatory Response during Cardiac
Surgery |
 |
T. Kawamura |
|
2) |
Modulation of the Inflammatory Response during Cardiac
Surgery |
|
J. Levy |
|
3) |
Severe Systemic Inflammation |
|
E. Berendes |
|
|
|
|
|
|
|
|
| September 11, 9:00-10:30 |
Pegasus2
|
|
|
|
Moderator |
|
Co-Moderator |
| 13. |
Neuroprotection |
M. Newman |
|
K. Tada |
|
 |
1) |
Neurologic Consequences of Cardiac Surgery |
 |
M. Newman |
|
2) |
Perioperative Neuroprotection in Cardiac Surgery |
|
T. Goto |
|
3) |
Protecting the Spinal Cord during Circulatory Arrest |
|
N. Nussmeier |
|
|
|
|
|
|
|
|
| September 11, 11:00-12:00 |
Pegasus2
|
|
|
|
Moderator |
|
Co-Moderator |
| 14. |
Pediatric Cardiac Surgery |
G. Wright |
|
T. Shin |
|
 |
1) |
athophysiology and Perioperative Management of Pulmonary
Hypertension |
 |
F. Ichinose |
|
2) |
Anesthetic Implications of the Norwood Procedure and
the Fontan Procedure for Single Ventricle Pediatric Patients |
|
S. Uezono |
|
|
|
| |
|
|

| Safe CPB depends on effective communication and close
coordination of activities by everyone on the OR team,
and hence anesthesiologists bear the responsibility of
understanding the basic principles of CPB. The CPB workshop
is intended to assist anesthesiologists in understanding
the CPB components and their functions through actual
operation of CPB mock circuits. |
|
|
| September 9, 15:15-16:45 |
Pegasus1
|
|
|
|
|
Moderator |
|
Co-Moderator |
|
|
Cardiopulmonary Bypass workshop |
Y. Niimi |
|
G. Silvay |
|
|
 |
1) |
Complications during CPB
|
 |
Y. Niimi, T. Matsui,
N. Kin |
|

 |
1. |
Beginner 1 (Japanese Session)
Sept. 10, Friday
|
Moderator: Y. Oka, R. Omoto
|
| 13:30-13:50 |
1. Principle, Indications
and safety |
M.
Kikura |
| 13:50-14:10 |
2. Image Optimization |
M.
Tagawa |
| 14:10-14:30 |
3. Anatomy |
S.
Akamatsu |
|
break
|
| 14:50-15:10 |
4. Evaluation of Global
Function |
T.
Yamada |
| 15:10-15:30 |
5. Evaluation of Regional
Function |
M
Iwade |
| 15:30-15:50 |
6. Basic Mitral Valve |
M.
Sato |
| 15:50-16:10 |
7. Basic Aortic Valve |
Y.
Onishi |
|
|
|
|
|
|
2. |
Beginner 2 (Japanese Session) |
|
|
Sept. 11, Saturday
|
Moderater: M. Nomura
|
| 16:00-16:20 |
8. Basic Densities
and Defects |
H.
Okamoto |
| 16:20-16:40 |
9. Basic Thoracic
Aorta |
K.
Fujimoto |
| 16:40-17:00 |
10. Artifacts and
Pitfalls |
Y.
Koide |
|
break
|
| 17:20-17:40 |
11. Tricuspid and
Pulmonary Valves |
M.
Nomura |
| 17:40-18:00 |
12. Relationship of
Surgery and TEE |
S.
Kyo |
| 18:00-18:20 |
13. Surgical Considerations
in Aortic Surgery |
k.
Orihashi |
|
|
|
|
|
|
3. |
Advance 1 (English Session) |
|
|
Sept. 11, Saturday
|
Moderater: D. Thys,
|
| 9:00-9:20 |
1. Quantitative Hemodynamics |
J.
Shanewise |
| 9:20-9:40 |
2. Systolic Function |
M.
London |
| 9:40-10:00 |
3. Evaluation of Hypotension |
J.
Hultman |
|
break
|
| 10:20-10:40 |
4. Aortic Stenosis |
Z.
Hillel |
| 10:40-11:00 |
5. Aortic Regurgitation |
S.
Aronson |
| 11:00-11:20 |
6. Mitral Stenosis |
S.
Reeves |
| 11:20-11:40 |
7. Mitral Regurgitation |
S.
Konstadt |
|
|
|
|
|
|
4. |
Advance 2 (English Session) |
|
|
Sept. 11, Saturday
|
Moderater: R. Savage
|
| 13:30-13:50 |
8. Prosthetic Valves |
J.
Mark |
| 13:50-14:10 |
9. Endocarditis |
K.Grickhnik |
| 14:10-14:30 |
10. Thoracic Aorta |
A.
Cheung |
|
break
|
| 14:50-15:10 |
11. Pericardial Disease |
R.
Savage |
| 15:10-15:30 |
12. Diastolic Function |
S.
Shernan |
| 15:30-15:50 |
13. Congenital |
I.
Russel |
|
|



|
|
|
Lunch
Session |
|
Pulse Oximetry and Pulse Dye-Densitometry
|
|
12:30-13:30 Pegasus1
|
|
Moderator:K.Hanaoka
The University of Tokyo, Japan |
|
 |
1) |
History and Futureand
T. Aoyagi Nihon Kohden Corporation,
Japan |
|
2) |
Clinical Importance
T. Iijima Kyorin University School
of Medicine, Japan |
|
|
NIHON KOHDEN CORPORATION
|
|
|
|
| |
| |
The Role of Phosphodiesterase III Inhibitor
Milrinone in Perioperative Low Cardiac Output Syndrome |
|
12:30-13:30 Pegasus1
|
| |
Moderator:K.
MoritaOkayama University Medical School, Japan |
| |
 |
|
N. Katori School of Medicine,
Keio University, Japan |
| |
|
Yamanouchi Pharmaceutical Co., Ltd.
|
|
|
|
| |
|
|
|
12:30-13:30 Apollon
|
|
Moderator:S.
MoritaTeikyo University School of Medicine, Japan |
|
 |
1) |
Mg during Cardiac Crises
T. ShireyNova Biomedical Corporation,
USA |
|
2) |
Gas Reception and Hb
M. Suematsu School of Medicine, Keio
University, Japan |
|
|
MC Medical, Inc.
|
|
|
|
| |
| |
Acute Lung Injury and Neutrophil Elastase |
|
12:30-13:30 Orion
|
| |
Moderator:H.
Furuya Nara Medical University, Japan
|
| |
 |
|
A. Ishizaka School of Medicine, Keio University,
Japan |
|
|
ONO PHARMACEUTICAL CO., LTD.
|
|
| |
|
Evening Session
|
|
Usefulness of PA Catheter during Cardiovascular
Surgery: Pro and Con |
|
17:00-18:00 Apollon
|
|
Moderator:E.
Inada Juntendo University, School of Medicine, Japan |
|
 |
|
S. KonstadtMount Sinai Medical Center,
USA |
|
|
N. KinThe University of Tokyo, Japan |
|
|
Edwards Lifesciences Limited
|
|
|
|
| |
|
Oximetry in Pediatric Cardiac Anesthesia |
|
18:00-19:00 Apollon
|
|
Moderator:H.
ObaraKobe University Graduate School of Medicine, Japan |
|
 |
|
S. Uezono Tokyo Women's Medical
University, Japan |
|
|
Tyco Healthcare Japan Inc.
|
|
|
|
| |
| |
The Computerised Data Record as a Risk Management
Tool in the OR and ICU |
|
17:00-18:00 Orion
|
| |
Moderator:Y.
Koide Yokohama City University Medical Center, Japan |
| |
 |
|
E. Segal Sheba Medical Center,
Israel |
|
|
FUKUDA DENSHI CO., LTD.
|
|
|
|
| |
| |
New Device for Arterial Cannulation |
|
18:00-19:00 Orion
|
| |
Moderator:M.
Kuro National Cardiovascular Center, Japan |
| |
Moderator:K.
Sumi kawaNagasaki University School of Medicine, Japan |
| |
 |
|
O. UchidaNational Cardiovascular Center,
Japan |
|
|
M. NomuraTokyo Women's Medical University,
Japan |
|
|
S. MukaiTokyo Women's Medical University,
Japan |
|
|
Nippon Becton Dickinson Company, Ltd.
|
|
| |
|
|
|
|
|
|
|
Lunch
Session |
|
Medical Photonics |
|
12:15-13:15 Pegasus1
|
|
Moderator:R.
OchiaiSchool of Medicine, Toho University, Japan |
|
 |
|
H. HirumaHAMAMATSU PHOTONICS
K.K., Japan |
|
|
HAMAMATSU PHOTONICS K.K.
|
|
|
|
| |
| |
PDEIII Inhibitors in Cardiovascular
Anesthesia: Current Uses and Therapeutic Potential |
|
12:15-13:15 Pegasus1
|
| |
Moderator:Y.
KammuraKagoshima University, School of Medicine, Japan |
| |
 |
1) |
From USA
F. IchinoseHarvard Medical School,
Massachusetts General Hospital, USA |
| |
2) |
From Japan
H. OkamotoKitasato University, School
of Medicine, Japan |
| |
|
Eisai Co., Ltd.
|
|
|
|
| |
|
New Methods of Mechanical Ventilation:
Benefits of Spontaneous Breathing during Weaning of Cardiothoracic
Surgery Patients
|
|
|
|
Moderator:S.
MoritaTeikyo University School of Medicine, Japan |
|
 |
1) |
O. Kenmotsu Hokkaido University School
of Medicine, Japan |
|
2) |
R. Kuhlen University Aachen, Germany |
|
|
Draeger Medical Japan Ltd.
|
|
|
|
| |
| |
Patient Benefit and Clinical Advantages
of an Ultra Short Opioid in Cardiac Anesthesia |
|
12:15-13:15 Orion
|
| |
Moderator:H.
Morisaki School of Medicine, Keio University, Tokyo
|
| |
 |
|
D. Royston Harefield Hospital, UK |
|
|
JANSSEN PHARMACEUTICAL K.K.
|
|
| |
|
Evening Session
|
|
Recent Technology for Non-invasive
Method of Impedance Cardiograph |
|
17:00-18:00 Apollon
|
|
Moderator:R.
Chuma Hyogo Brain and Heart Center at Himeji, Japan |
|
 |
|
S. Sageman Natividad Medical Center, USA |
|
|
GE Yokogawa Medical Systems Japan,
Ltd.
|
|
|
|
| |
|
|
|
18:00-19:00 Apollon
|
|
Moderator:A.
NamikiSapporo Medical University School of Medicine, Japan |
|
 |
1) |
Intensive Care Sedation Using Dexmedetomidine -New Developments-
M. NomuraTokyo Women's Medical University,
Japan |
|
2) |
Alpha-2 Agonists in the Perioperative Period: New Comfort
for the Critically Ill?
R. SladenCollege of Physicians and
Surgeons of Columbia University, New York, USA |
|
|
|
| |
| |
Maruishi Pharmaceutical Co., Ltd./ABBOTT
JAPAN CO., LTD.
Mechanism of Ischemic Preconditioning and Its Clinical Application |
|
17:00-19:00 Orion
|
| |
Moderator:R.
OgawaNippon Medical School, Japan |
| |
 |
1) |
Intracellular Mechanisms of Preconditioning -Mitochondrial
ATP Sensitive Potassium Channel or Permeability Transition
Pore?
T. Miura Sapporo Medical University,
Japan |
|
2) |
Nicorandil Decreases the Likelihood of Cardiac Events
During and After Noncardiac Surgery
S. Kashimoto Faculty of Medicine,
University of Yamanashi, Japan |
|
3) |
Impact of Nicorandil in Angina. Final Results and Sub-Study
I. Ford University of Glasgow, UK |
|
|
CHUGAI PHARMACEUTICAL CO., LTD.
|
|
|
|
|
|
|
|
|
|
|
|
|
Lunch
Session |
|
TEE and Pediatric Surgery |
|
12:15-13:15 Pegasus1
|
|
Moderator:R.
OmotoSaitama Medical School Hospital, Japan |
|
| | |